Association Between the hsa-mir-27a Variant and Breast Cancer Risk: a Meta-analysis

  • Wang, Bin (Department of Oncology, Changhai Hospital, The Second Military Medical University) ;
  • Ma, Ning (Clinical Laboratory, 85th Hospital of PLA) ;
  • Wang, Yajie (Department of Oncology, Changhai Hospital, The Second Military Medical University)
  • Published : 2012.12.31


Introduction: Although a number of studies were published in the past several years on associations between hsa-mir-27a and cancer risk, the findings remain conflicting rather than conclusive. To derive a more precise effect on the association between SNP hsa-mir-27a rs895819 and breast cancer risk, we conducted a meta-analysis for the first time. Materials and Methods: Through retrieval from PubMed for the period up to August 2012, a total of four studies were identified with 3,287 cases and 4,298 controls for SNP hsa-mir-27a rs895819. We calculated summary odds ratio (ORs) and corresponding 95% confidence intervals (CIs) using a fixed effects model (when the heterogeneity was absent, P>0.10). Otherwise, the random-effects model was used. Results: We found that hsa-mir-27a rs895819 polymorphism also did not reveal any relationship with breast cancer susceptibility (AG versus AA: OR = 0.98; 95%CI, 0.73-1.32; GG versus AA: OR = 0.86; 95% CI, 0.72-1.03; AG/GG versus AA: OR = 0.92; 95% CI, 0.74-1.14), while significantly decreased risk was found among Europeans in AG versus AA and AG/GG versus AA models tested (AG versus AA: OR = 0.83; 95%CI, 0.72-0.97; GG versus AA: OR = 0.86; 95% CI, 0.71-1.05; AG/GG versus AA: OR = 0.84; 95% CI, 0.75-0.94). Conclusion: These findings suggest that hsa-mir-27a rs895819 polymorphism may play an important role in breast cancer development.


Breast cancer;meta;analysis;gene polymorphism;ethnic groups


  1. Ma Y, Yu S, Zhao W, et al (2010). miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Letters, 298, 150-8.
  2. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  3. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Research, 67, 11001-11.
  4. Narod SA (2002). Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer, 2, 113-23.
  5. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
  6. Pharoah PD, Antoniou A, Bobrow M, et al (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet, 31, 33-6.
  7. Porkka KP, Pfeiffer MJ, Waltering KK, et al (2007). MicroRNA expression profiling in prostate cancer. Cancer Res, 67, 6130-5.
  8. Ryan BM, Robles AI, Harris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancerb, 10, 389-402.
  9. Sun Q, Gu H, Zeng Y, et al (2010). Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci, 101, 2241-7.
  10. Tchatchou S, Jung A, Hemminki K, et al (2009). A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis, 30, 59-64.
  11. Tran N, McLean T, Zhang X, et al (2007). MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun, 358, 12-7.
  12. Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 103, 2257-61.
  13. Yang R, Schlehe B, Hemminki K, et al (2010). A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat, 121, 693-702.
  14. Zhang M, Jin M, Yu Y, et al (2012). Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care, 21, 274-80.
  15. Brennecke J, Hipfner DR, Stark A, et al (2003). Bantam encodes a evelopmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36.
  16. Catucci I, Verderio P, Pizzamiglio S, et al (2012). The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat, 133, 805-7.
  17. Chan JA, Krichevsky AM, Kosik KS (2004). MicroRNA-21 is an antiapoptotic factor n human glioblastoma cells. Cancer Res, 65, 6029-33.
  18. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
  19. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
  20. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
  21. Hopper JL (2001). Genetic epidemiology of female breast cancer. Semin Cancer Biol, 11, 367-74.
  22. Hu J, Zhou GW, Wang N, et al (2010). MTRR A66G polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 124, 779-84.
  23. Hu J, Zhou GW, Wang N, et al (2010). GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 124, 425-31.
  24. Kapeller J, Houghton LA, Mönnikes H, et al (2009). First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptortype 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet, 17, 2967-77.
  25. Lagos-Quintana M, Rauhut R, Lendeckel W, et al (2001). Identification of novel genes coding for small expressed RNAs. Science, 294, 853-8.
  26. Landi D, Gemignani F, Naccarati A, et al (2008). Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis, 29, 579-84.
  27. Lau NC, Lim LP, Weinstein EG, et al (2001). An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans. Science, 294, 858-62.
  28. Le Quesne J, Caldas C (2010). Micro-RNAs and breast cancer. Mol Oncol, 4, 230-41.
  29. Lee RC, Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science, 294, 862-4.
  30. Li X, Mertens-Talcott SU, Zhang S, Kim K, et al (2010) .MicroRNA-27a indirectly regulates estrogen receptor a expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology, 151, 2462-73.

Cited by

  1. Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis vol.8, pp.6, 2013,
  2. Association Between the Pre-mir-218 Polymorphism and Cancer Risk in the Chinese Population: a Meta-Analysis vol.15, pp.6, 2014,
  3. Association of a Pre-miR-27a Polymorphism with Cancer Risk: an Updated Meta-analysis vol.15, pp.23, 2015,